Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Shuttle Pharmaceuticals Holdings, Inc. ( (SHPH) ) is now available.
On November 3, 2025, Shuttle Pharmaceuticals Holdings, Inc. entered into a securities purchase agreement to issue and sell a pre-funded warrant for 625,156 shares of common stock, raising approximately $2.5 million in a private placement. The offering closed on November 4, 2025, and includes provisions for the exercise of the warrant and filing of a registration statement with the SEC. The transaction was facilitated by WestPark Capital, Inc. as the placement agent, with the company agreeing to certain restrictions on issuing additional shares for a period following the offering.
Spark’s Take on SHPH Stock
According to Spark, TipRanks’ AI Analyst, SHPH is a Underperform.
Shuttle Pharmaceuticals Holdings, Inc. faces significant financial challenges with no revenue and ongoing cash burn. Technical indicators show bearish trends, and valuation metrics highlight the company’s unprofitability. While recent corporate activities offer potential strategic benefits, they also add financial strain and governance complexities, leading to an overall low stock score.
To see Spark’s full report on SHPH stock, click here.
More about Shuttle Pharmaceuticals Holdings, Inc.
Average Trading Volume: 219,934
Technical Sentiment Signal: Sell
Current Market Cap: $2.86M
See more data about SHPH stock on TipRanks’ Stock Analysis page.